Biogen CEO plots long-term turnaround after analysts brand company's recent results as 'weak'
Biogen CEO plots long-term turnaround after analysts brand company's recent results as 'weak' fkansteiner Tue, 02/13/2024 - 10:58
Biogen CEO plots long-term turnaround after analysts brand company's recent results as 'weak' fkansteiner Tue, 02/13/2024 - 10:58
Lawmakers urge White House officials to enforce sanctions on China's WuXi AppTec, WuXi Biologics: Reuters zbecker Tue, 02/13/2024 - 10:56
Incyte crosses $1B in quarterly revenue for the first time, even as Jakafi faces off against GSK rival aliu Tue, 02/13/2024 - 10:44
PhRMA lawsuit challenging IRA price negotiations dismissed on jurisdictional technicality kdunleavy Tue, 02/13/2024 - 10:11
Thermo Fisher expands partnership with Multiply Labs to automate cell therapy production jkeenan Tue, 02/13/2024 - 07:12
In wake of Reata buyout, Biogen's key launch Skyclarys passes muster in EU fkansteiner Mon, 02/12/2024 - 16:57